Stay updated on IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedAdded a government funding lapse notice and updated the page revision to v3.4.1, while removing the previous v3.4.0 reference.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page adds a glossary toggle label and minor wording changes to QC status and FEAR Act data. A revision footer indicates version 3.4.0.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter revision updated to v3.3.4 (from v3.3.3). This is a minor metadata update with no impact on the study information or navigation.SummaryDifference0.1%

- Check38 days agoChange DetectedPublication added in Publications From PubMed: Barbour et al., Kidney Int. 2025 (online ahead of print), a single-arm phase 2 trial related to IgA nephropathy. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedConsolidated location headings into a single 'Locations' section listing New South Wales, Victoria, British Columbia, and Ontario. The footer revision label updated to v3.3.3 and the 'HHS Vulnerability Disclosure' link was removed.SummaryDifference0.6%

- Check74 days agoChange DetectedThe Publications section was updated to indicate PubMed auto-fills publications and may not be about the study, and to display Revision: v3.3.2. The previous PubMed note (Revision: v3.2.0) was removed.SummaryDifference0.1%

Stay in the know with updates to IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.